Table 2.
Attitudes towards pharmacogenetic testing among 20 medical cannabis patients in Toronto, Canada
| 1. Do you think you will change your cannabis usage due to the test results? | |
| Stop completely | 15% |
| Reduce use | 5% |
| No change | 75% |
| Increase use | 5% |
| 2. Did the test results change your comfort level in choosing a specific strength/strain of cannabis? | |
| Less comfortable | 0% |
| No change | 35% |
| More comfortable | 65% |
| 3. Do you think pharmacists should be more involved in advising on cannabis use? | |
| No | 5% |
| Neutral | 5% |
| Yes | 90% |
| 4. What is the impact/value of the genetic results regarding cannabis use? | |
| Low | 10% |
| Neutral | 15% |
| High | 75% |
| 5. What is the impact/value of the pharmacist’s consult towards safe cannabis use? | |
| Low | 0% |
| Neutral | 5% |
| High | 95% |
During the consultation, the pharmacist would assess the participants’ current or potential use of cannabis and their potential risk for adverse effects. Strategies to mitigate the risk were also recommended by the pharmacist based on the individual’s genetic profile. Participants were then asked to complete a post-test questionnaire assessing the perceived value of both the pharmacogenetic testing and the pharmacist’s consultation on influencing the safe use of cannabis with results shown